MarketCap
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
2018 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBAL |
Anteile |
66 M |
Marktkapitalisierung |
$ 177 M |
EBITDA (LTM) |
$ -28 M |
P/E (LTM) |
-4.881356 |
P/S (LTM) |
1.273416 |
EPS (LTM) |
-0.59 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Trinity Biotech plc
TRIB
|
$ 6.43 | -2.02 % | $ 2.31 B | Nasdaq Global Select Market |  Irlanda |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 27.03 | 12.3 % | $ 605 M | Nasdaq Global Select Market | USA |
 |
Twist Bioscience Corporation
TWST
|
$ 142.53 | 1.59 % | $ 8.52 B | Nasdaq Global Select Market,SPB | USA |
 |
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | USA |
 |
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | USA |
 |
PerkinElmer
PKI
|
- | -0.91 % | $ 14.7 B | NYSE,SPB | USA |
 |
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Guardant Health
GH
|
$ 171.03 | -2.27 % | $ 21.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Interpace Biosciences
IDXG
|
$ 5.72 | 5.1 % | $ 25.3 M | Nasdaq Global Select Market | USA |
 |
Illumina
ILMN
|
$ 226.55 | -4.89 % | $ 35.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Celcuity
CELC
|
$ 69.03 | -0.73 % | $ 3.23 B | Nasdaq Global Select Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 367.96 | 3.97 % | $ 30.6 B | NYSE,SPB | USA |
 |
Medpace Holdings
MEDP
|
$ 656.33 | -1.08 % | $ 18.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 332.3 | -5.56 % | $ 16.5 B | NYSE,SPB | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 723.68 | 1.51 % | $ 35.5 B | NYSE,SPB |  Schweiz |
 |
Castle Biosciences
CSTL
|
$ 35.78 | 1.82 % | $ 1.04 B | Nasdaq Global Market,SPB | USA |
 |
T2 Biosystems
TTOO
|
- | -39.35 % | $ 313 K | Nasdaq Global Select Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
QIAGEN N.V.
QGEN
|
$ 50.86 | 0.95 % | $ 11 B | NYSE |  Niderland |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Brainsway Ltd.
BWAY
|
$ 11.19 | 0.36 % | $ 380 M | Nasdaq Global Select Market | Israel |
 |
Quest Diagnostics Incorporated
DGX
|
$ 255.64 | 3.47 % | $ 28.4 B | NYSE,SPB | USA |
 |
Waters Corporation
WAT
|
$ 470.44 | 2.29 % | $ 28 B | NYSE,SPB | USA |
 |
Exagen
XGN
|
$ 8.51 | 2.04 % | $ 183 M | Nasdaq Global Market | USA |
 |
Danaher Corporation
DHR
|
$ 235.76 | 2.46 % | $ 168 B | NYSE,SPB | USA |
 |
DexCom
DXCM
|
$ 88.86 | 7.1 % | $ 34.7 B | Nasdaq Global Select Market,SPB | USA |
 |
Quotient Limited
QTNT
|
- | -11.32 % | $ 1.1 M | Nasdaq Global Select Market | Schweiz |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Surmodics
SRDX
|
- | - | $ 608 M | Nasdaq Global Select Market,SPB | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
 |
Syneos Health
SYNH
|
- | - | $ 4.46 B | Nasdaq Global Select Market,SPB | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Lantheus Holdings
LNTH
|
$ 101.13 | 0.32 % | $ 6.83 B | Nasdaq Global Select Market,SPB | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Renalytix AI plc
RNLX
|
- | 5.66 % | $ 22.7 M | Nasdaq Global Market |  Britain |
 |
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | USA |
 |
Meridian Bioscience
VIVO
|
- | - | $ 1.49 B | Nasdaq Global Select Market | USA |
 |
RadNet
RDNT
|
$ 80.39 | 9.85 % | $ 6.04 B | Nasdaq Global Select Market | USA |